+163.2%
BBIO vs SBAC
-10.2%
+173.4%
-92.8%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | SBAC | Excess | Alpha |
|---|---|---|---|---|
| 1D | -4.7% | -2.8% | -1.9% | -3.8% |
| 7D | -3.9% | -5.3% | +1.4% | -2.2% |
| 30D | -13.4% | +0.4% | -13.8% | -13.6% |
| 3M | +7.6% | -11.9% | +19.5% | +11.4% |
| 6M | -2.4% | -4.5% | +2.0% | -2.7% |
| YTD | -5.2% | -4.3% | -0.9% | -5.7% |
| 1Y | +36.9% | -3.9% | +40.8% | +35.6% |
| 3Y | +155.2% | -11.0% | +166.2% | +154.4% |
| 5Y | +44.0% | -44.1% | +88.1% | +71.8% |
| All | +163.2% | -10.2% | +173.4% | +183.2% |
Cumulative growth
Daily Returns
Daily percentage return beside SBAC.
Daily Out/Under-Performance
Portfolio return minus SBAC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × SBAC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded SBAC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling